Patents Assigned to Verigraft AB
  • Publication number: 20230093436
    Abstract: The present disclosure relates to methods of preparing personalized blood vessels, useful for transplantation with improved host compatibility and reduced susceptibility to thrombosis. Also provided are personalized blood vessels produced by the methods and use thereof in surgery.
    Type: Application
    Filed: October 17, 2022
    Publication date: March 23, 2023
    Applicant: VeriGraft AB
    Inventor: Raimund Strehl
  • Patent number: 11471567
    Abstract: The present disclosure relates to methods of preparing personalized blood vessels, useful for transplantation with improved host compatibility and reduced susceptibility to thrombosis. Also provided are personalized blood vessels produced by the methods and use thereof in surgery.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: October 18, 2022
    Assignee: VeriGraft AB
    Inventor: Raimund Strehl
  • Patent number: 10980916
    Abstract: The present disclosure relates to methods of preparing personalized blood vessels, useful for transplantation with improved host compatibility and reduced susceptibility to thrombosis. Also provided are personalized blood vessels produced by the methods and use thereof in surgery.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: April 20, 2021
    Assignee: VeriGraft AB
    Inventor: Raimund Strehl
  • Publication number: 20200383785
    Abstract: The present disclosure relates to methods for recellularization of valves in valve-bearing veins. This method is useful for producing an allogeneic venous valve, wherein a donor valve-bearing vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic valves produced by the methods disclosed herein are advantageous for implantation, transplantation, or grafting into patients with vascular diseases.
    Type: Application
    Filed: June 4, 2020
    Publication date: December 10, 2020
    Applicant: VeriGraft AB
    Inventors: Suchitra SUMITRAN-HOLGERSSON, Antonio Rosales, Jonny Hisdal
  • Publication number: 20200147272
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: December 27, 2019
    Publication date: May 14, 2020
    Applicant: VeriGraft AB
    Inventors: Suchitra SUMITRAN-HOLGERSSON, Michael OLAUSSON
  • Publication number: 20200038556
    Abstract: The present disclosure relates to methods of preparing personalized blood vessels, useful for transplantation with improved host compatibility and reduced susceptibility to thrombosis. Also provided are personalized blood vessels produced by the methods and use thereof in surgery.
    Type: Application
    Filed: September 20, 2019
    Publication date: February 6, 2020
    Applicant: VeriGraft AB
    Inventor: Raimund Strehl
  • Publication number: 20200038555
    Abstract: The present disclosure relates to methods of preparing personalized blood vessels, useful for transplantation with improved host compatibility and reduced susceptibility to thrombosis. Also provided are personalized blood vessels produced by the methods and use thereof in surgery.
    Type: Application
    Filed: August 2, 2019
    Publication date: February 6, 2020
    Applicant: VeriGraft AB
    Inventor: Raimund Strehl
  • Patent number: 10517996
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: December 31, 2019
    Assignee: Verigraft AB
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson